Therapeutic Drug Monitoring of Adalimumab in Psoriasis Patients

Trial Profile

Therapeutic Drug Monitoring of Adalimumab in Psoriasis Patients

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 16 Jun 2015

At a glance

  • Drugs Adalimumab (Primary)
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Jun 2015 Planned End Date changed from 1 Jun 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
    • 03 Jun 2015 Planned primary completion date changed from 1 Jun 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
    • 03 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top